http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1512771-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c644138f2071b48b5991a1425d8dde0a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54
filingDate 1977-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1978-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1512771-A
titleOfInvention Piperazinyluracil salt
abstract 1512771 Compositions containing urapidil and furosemide BYK GULDEN LOMBERG CHEMISCHE FABRIK GmbH 7 Feb 1977 [9 Feb 1976] 4900/77 Heading A5B [Also in Division C2] The invention provides antihypertensive compositions containing the compounds (II) and (III), or a 1:1 salt thereof. Conventional modes of administration are described.
priorityDate 1976-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552984
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533897
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414024105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53763339

Total number of triples: 23.